Sebastian Oltean

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Venues

Cancer research

Scientific reports

The Journal of physiology

Oncogenesis

University of Exeter Medical School

University of Nebraska-Lincoln (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Exeter Medical School Mar 16 2020

United Kingdom

Associate Professor in Experimental Medicine and Therapeutics :: Institute of Biomedical and Clinical Sciences

University of Exeter Medical School Mar 06 2017 - Mar 16 2020

United Kingdom

Senior Lecturer in Experimental Medicine and Therapeutics

University of Bristol Apr 05 2012 - Mar 03 2017

United Kingdom

Independent research fellow/ PI / honorary lecturer :: Physiology, Pharmacology and Neurosciences / Bristol Renal

University of Bristol Oct 07 2008 - Mar 30 2012

United Kingdom

postdoctoral researcher :: Physiology, Pharmacology, Neurosciences

Duke University Aug 01 2004 - Sep 30 2008

United States

postdoctoral researcher :: Molecular Genetics

Iuliu Hațieganu University of Medicine and Pharmacy Sep 15 1996 - Dec 15 1998

Romania

junior doctor :: Nephrology and Dialysis

Education History

University of Nebraska-Lincoln Jan 06 1999 - May 05 2004

United States

PHD

University of Medicine Sep 15 1990 - Jun 15 1996

Romania

PHD

Publications

Ling Li, Jinxia Zheng, Sebastian Oltean
Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics. Genes 14 (11) (2023)
Simon Uzor, Sean R Porazinski, Ling Li, Bethany Clark, Masahiko Ajiro, Kei Iida, Masatoshi Hagiwara, Abdullah A Alqasem, Claire M Perks, Ian D Wilson, Sebastian Oltean, Michael R Ladomery
CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer. Scientific reports 11 (1) (2021)
Eleanor Star, Megan Stevens, Clare Gooding, Christopher W J Smith, Ling Li, Monica Lamici Ayine, Steve J Harper, David Owen Bates, Sebastian Oltean
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties. Oncogenesis 10 (5) (2021)
Philip Kitchen, Ka Ying Lee, Danielle Clark, Nikki Lau, Jomnarong Lertsuwan, Anyaporn Sawasdichai, Jutamaad Satayavivad, Sebastian Oltean, Simon Afford, Kevin Gaston, Padma-Sheela Jayaraman
A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer research 80 (4) (2019)
Megan Stevens, Christopher R Neal, Elena C Craciun, Maria Dronca, Steven J Harper, Sebastian Oltean
The natural drug DIAVIT is protective in a type II mouse model of diabetic nephropathy. PloS one 14 (3) (2019)
Sebastian Oltean, Richard Coward, Massimo Collino, Hans Baelde
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues. BioMed research international 2017 (2017)
Megan Stevens, Christopher R Neal, Andrew H J Salmon, David Owen Bates, Steven J Harper, Sebastian Oltean
VEGF-A165 b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney. The Journal of physiology 595 (19) (2017)

Sebastian Oltean.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sebastian Oltean